Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Osimertinib Improves Overall Survival in EGFR-Mutated Non-Small Cell Lung Cancer Patients With Leptomeningeal Metastases Regardless of T790M Mutational StatusJ Thorac Oncol 2020 Jul 08;[EPub Ahead of Print], J Lee, Y La Choi, J Han, S Park, HA Jung, JM Sun, SH Lee, JS Ahn, K Park, MJ Ahn
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Brain Cancer Center of Excellence
Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.